Cargando…
Artesunate induces ferroptosis by inhibiting the nuclear localization of SREBP2 in myeloma cells
Objective: Multiple myeloma (MM) is an incurable haematological cancer characterized by abnormal proliferation of plasma cells. The promising therapeutic effect of selective inhibitors of nuclear export in MM reveals the broad therapeutic prospects of nuclear localization intervention. Sterol regula...
Autores principales: | Liang, Laoqi, Liu, Yang, Wu, Xiaoyan, Chen, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583180/ https://www.ncbi.nlm.nih.gov/pubmed/37859702 http://dx.doi.org/10.7150/ijms.86409 |
Ejemplares similares
-
Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis
por: Roh, Jong-Lyel, et al.
Publicado: (2016) -
Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells
por: Eling, Nils, et al.
Publicado: (2015) -
Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells
por: Wang, Kang, et al.
Publicado: (2019) -
Artesunate overcomes drug resistance in multiple myeloma by inducing mitochondrial stress and non-caspase apoptosis
por: Papanikolaou, Xenofon, et al.
Publicado: (2014) -
Inhibition of SREBP1 sensitizes cells to death ligands
por: Eberhard, Yanina, et al.
Publicado: (2011)